@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

<http://fhir.ch/ig/ch-epl/AdministrableProductDefinition/PhP-Trientinum-250mg-Capsule> a fhir:AdministrableProductDefinition ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "PhP-Trientinum-250mg-Capsule"] ; # 
  fhir:meta [
     fhir:profile ( [
       fhir:v "http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-administrableproductdefinition"^^xsd:anyURI ;
       fhir:link <http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-administrableproductdefinition>
     ] )
  ] ; # 
  fhir:text [
     fhir:status [ fhir:v "generated" ] ;
     fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: AdministrableProductDefinition PhP-Trientinum-250mg-Capsule</b></p><a name=\"PhP-Trientinum-250mg-Capsule\"> </a><a name=\"hcPhP-Trientinum-250mg-Capsule\"> </a><a name=\"PhP-Trientinum-250mg-Capsule-en-US\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-ch-idmp-administrableproductdefinition.html\">CH IDMP AdministrableProductDefinition</a></p></div><p><b>status</b>: Active</p><p><b>formOf</b>: <a href=\"MedicinalProductDefinition-Triogen-250mg-Capsule.html\">MedicinalProductDefinition: extension = Capsule, hard,TRIOGEN wird vergütet zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Patienten, die eine Behandlung mit D-Penicillamin nicht vertragen. Die Behandlung muss von Gastroenterologen oder Hepatologen mit Erfahrung bei der Behandlung von Patienten mit Morbus Wilson initiiert und überwacht werden.; identifier = http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MPID#CH-7601001403062-6743101; domain = Human; indication = Zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Patienten, die eine Behandlung mit D-Penicillamin nicht vertragen.; legalStatusOfSupply = Medicinal product subject to medical or veterinary prescription (B); additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Authorised for the treatment in children; classification = trientine,NA KAS art. 12 para. 5 TPLO,Synthetic,Originator product</a></p><p><b>administrableDoseForm</b>: <span title=\"Codes:{http://standardterms.edqm.eu 10210000}\">Capsule, hard</span></p><p><b>unitOfPresentation</b>: <span title=\"Codes:{http://standardterms.edqm.eu 15012000}\">Capsule</span></p><h3>RouteOfAdministrations</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://standardterms.edqm.eu 20053000}\">Oral use</span></td></tr></table></div>"^^rdf:XMLLiteral
  ] ; # 
  fhir:status [ fhir:v "active"] ; # 
  fhir:formOf ( [
     fhir:link <http://fhir.ch/ig/ch-epl/MedicinalProductDefinition/Triogen-250mg-Capsule> ;
     fhir:reference [ fhir:v "MedicinalProductDefinition/Triogen-250mg-Capsule" ]
  ] ) ; # 
  fhir:administrableDoseForm [
     fhir:coding ( [
       fhir:system [ fhir:v "http://standardterms.edqm.eu"^^xsd:anyURI ] ;
       fhir:code [ fhir:v "10210000" ] ;
       fhir:display [ fhir:v "Capsule, hard" ]
     ] )
  ] ; # 
  fhir:unitOfPresentation [
     fhir:coding ( [
       fhir:system [ fhir:v "http://standardterms.edqm.eu"^^xsd:anyURI ] ;
       fhir:code [ fhir:v "15012000" ] ;
       fhir:display [ fhir:v "Capsule" ]
     ] )
  ] ; # 
  fhir:routeOfAdministration ( [
     fhir:code [
       fhir:coding ( [
         fhir:system [ fhir:v "http://standardterms.edqm.eu"^^xsd:anyURI ] ;
         fhir:code [ fhir:v "20053000" ] ;
         fhir:display [ fhir:v "Oral use" ]
       ] )
     ]
  ] ) . # 

# -------------------------------------------------------------------------------------

